In vivo/in vitro correlations for four differently dissolving ketorolac tablets

Biopharmaceutics and Drug Disposition

Volumn 17, Issue 6, 1996, Pages 481-492

  Gordon, Marc S ^a,b   Chowhan, Zak ^a  

^a ROCHE BIOSCIENCE   (United States)

^b NEKTAR THERAPEUTICS   (United States)

Author keywords

bioavailability; dissolution; immediate release tablets; ketorolac; pharmacokinetics

Indexed keywords

KETOROLAC;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TABLET; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; HALF-LIFE; HUMANS; KETOROLAC; MALE; SOLUBILITY; TABLETS; TOLMETIN;

EID: 0029815435     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199608)17:6<481::AID-BDD971>3.0.CO;2-G     Document Type: Article

References (14)

1. D. Jung, E. J. Mroszczak, A. Wu, T. L. Ling, H. Sevelius and L. Bynum, Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine. Pharm. Res., 6, 62-65 (1989).
2. E. J. Mroszczak, D. Jung, J. Yre, L. Bynum, H. Sevelius and I. Massey, Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy, 10, 33S-39S (1990).
3. D. R. Brocks and F. Jamali, Clinical pharmacokinetics of ketorolac tromethamine. Clin. Pharmacokinet., 415-427 (1992).
4. Physicians' Desk Reference, Medical Economics Data, Montvale, NJ, 1995, pp. 2492-2493.
5. M. S. Gordon, T. L. Ling and J. P. Yee, Ketorolac tromethamine bioavailability via tablet, capsule and oral solution dosage forms. Drug Dev. Ind. Pharm., 21, 1143-1155 (1995).
6. J. C. Shobha, K. R. Sekhar, E. C. Sekhar, T. R. Kumar Rao, P. A. Babu, M. U. R. Naidu and D. R. Krishna, Bioequivalence of ketorolac tablet in healthy volunteers. Ind. J. Pharm. Sci., 55, 105-107 (1993).
7. F. J. Flores-Murrieta, V. Granados-Soto, G. Castaneda-Hernandez, J. E. Herrera and E. Hong, Comparative bioavailability of two oral formulations of ketorolac tromethamine: Dolac and Exodol. Biopharm. Drug Disposit., 15, 129-136 (1994).
8. Ketorolac Tromethamine Tablets. Pharmacopoeial Forum, 20(3), 7372-7373 (1994).
9. M. Brandi, A. Magill, V. Rudraraju and M. S. Gordon, Approaches for improving the stability of ketorolac in powder blends. J. Pharm. Sci., 84(10), 1151-1153 (1995).
10. A. T. Wu, B. L. Huang, I. Massey and S. Kushinsky, Quantification of ketorolac in plasma and aqueous humor by high performance liquid chromatography. Am Pharm. Assoc. Abstracts, 16, 145 (1986).
11. B. J. Winer, Statistical Principles in Experimental Design, McGraw-Hill, San Francisco, 1971.
12. A. J. Barr, SAS User's Guide, 1982 edn, SAS Institute Inc., Cary, NC.
13. R. J. Miller, Simultaneous Statistical Inference, McGraw-Hill, New York, 1966, pp. 81-89.
14. D. J. Finney, Statistical Method in Biological Assay, 3rd edn, Macmillan, New York, 1971, pp. 80-89.